Graftech International Ltd: Form 10-Q for the period ended Sep 30, 2019
Filed with the SEC on Nov 7, 2019 and accepted by EDGAR at Nov 7, 2019, 16:51 ET.
Management's discussion and analysis
As filed, 47,686 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Outlook
GrafTech is a leading manufacturer of graphite electrodes, the critical consumable for the electric arc furnace ("EAF") industry. We are the only graphite electrode producer that is substantially vertically integrated into petroleum needle coke, the key raw material for graphite electrodes. Vertical integration has allowed us to adopt a commercial strategy with long-term, fixed price, fixed volume, take-or-pay contracts providing earnings stability and visibility. These contracts define volumes and prices, along with price‑escalation mechanisms for inflation, and include significant termination payments (typically, 50% to 70% of remaining contracted revenue) and, in certain cases, parent guarantees and collateral arrangements to manage our customer credit risk. The outstanding three‑to‑five‑year take‑or‑pay contracts represent approximately 146,000, 142,000, 125,000 and 117,000 metric tons ("MT") in 2019, 2020, 2021 and 2022, respectively. These amounts are slightly lower than amounts reported in previous quarters due to the financial condition of certain of our customers. Approximately 83% of these volumes are under pre-determined fixed annual volume contracts, while approximately 17% of the volumes are under contracts with a specified volume range. The aggregate difference between the midpoint and the minimum volumes across our cumulative portfolio of take-or-pay contracts with specified volume ranges is approximately 5,000 MT per year. Volumes per year may further vary based on the actual timing of product shipments and the financial condition of our customers. We have contracted approximately two-thirds of our production capacity through these contracts.
We have announced a series of operational improvement projects at our Monterrey and St. Marys facilities. These projects are intended to help optimize our manufacturing footprint while improving environmental performance and increasing production flexibility. We expect these projects to be completed in the first half of 2021, at which time we will be able to shift additional graphitization and machining from Monterrey to St. Marys. We estimate that capital spending would be near current levels which includes these projects as well as maintenance and capital projects, subject to the approval by our Board.
Our weighted average realized price of GrafTech manufactured electrodes was $9,960 per MT in the third quarter of 2019 compared to $9,664 per MT in the third quarter of 2018, which has been recast as described below. While spot prices have come down from recent historic highs, they still remain well above their historical average. Strong economics for the EAF producers that we serve has led to EAF production since 2016 resuming growth in line with its historical trend (2.8% annually from 1984-2017) in recent history. Steelmakers have announced EAF capacity expansions representing a potential 15 to 20% increase in graphite electrode demand in the U.S. by 2022. However, recent steel production and graphite electrode consumption has slowed in some regions, notably Europe and South America.
A tight needle coke market is also contributing to these elevated prices. Needle coke demand from electric vehicle batteries is currently disrupting the supply chain and resulting in increased pricing and higher costs of sales. Although our vertical integration largely protects us from the increase in needle coke costs, we expect to purchase approximately one third of our needle coke supply from third parties. These higher needle coke costs will continue to impact our earnings.
We are impacted in varying degrees, both positively and negatively, as global, regional or country economic conditions fluctuate. Our discussions about market data and global economic conditions below are derived from published industry accounts and statistics. In its October 2019 report, the International Monetary Fund ("IMF") reported that they were again lowering their 2019 growth forecast from their July forecast by 0.2% to 3.0% and lowering their 2020 forecast by 0.1% to 3.4%, as rising trade and geopolitical tensions have increased uncertainty about the future of the global trading system.
Graphite electrode demand is primarily linked to the global production of steel in EAFs, and to a lesser extent, with the total production of steel and certain other metals. The World Steel Association's ("WSA") October 2019 Short Range Outlook estimated that global steel demand outside of China increased by 1.6% in 2018, which was revised down 0.6% from their April 2019 estimate. WSA also decreased their growth forecast for steel demand outside of China for 2019 from 1.7% in their April forecast to 0.2% as uncertainty, trade tensions and geopolitical issues have weighed on investment and trade. WSA's growth forecast for steel demand outside of China for 2020 was revised down to 2.5% from their April estimate of 2.8%.
Key metrics used by management to measure performance
In addition to measures of financial performance presented in our Condensed Consolidated Financial Statements in accordance with GAAP, we use certain other financial measures and operating metrics to analyze the performance of our company. The “non‑GAAP” financial measures consist of EBITDA from continuing operations and adjusted EBITDA from continuing operations, which help us evaluate growth trends, establish budgets, assess operational efficiencies and evaluate our overall financial performance. The key operating metrics consist of sales volume, weighted average realized price, production volume, production capacity and capacity utilization.
Key financial measures
(in thousands)
| For the Three Months Ended September 30, 2019 | 2018 | For the Nine Months Ended September 30, 2019 | 2018 | |
|---|---|---|---|---|
| Net sales | $420,797 | $454,890 | $1,376,181 | $1,363,121 |
| Net income | 175,876 | 199,466 | 569,680 | 624,587 |
| EBITDA from continuing operations(1) | 242,026 | 274,406 | 802,569 | 807,317 |
| Adjusted EBITDA from continuing operations(1) | 245,454 | 276,812 | 813,673 | 879,108 |
(1) Non-GAAP financial measures; see below for information and a reconciliation of EBITDA and adjusted EBITDA to net income, the most directly comparable financial measure calculated and presented in accordance with GAAP.
Key operating metrics
In an effort to improve transparency, beginning in the first quarter of 2019, we recast the key operating metrics of sales volume and weighted average realized price per metric ton as set forth in the table below to include only graphite electrodes manufactured by GrafTech. This better reflects management’s assessment of our revenue and profitability and excludes re-sales of low grade graphite electrodes manufactured by third-party suppliers. For comparability purposes, the prior periods have been recast to conform to this presentation.
(in thousands, except price data)
| For the Three Months Ended September 30, 2019 | 2018 | For the Nine Months Ended September 30, 2019 | 2018 | |
|---|---|---|---|---|
| Sales volume (MT)(1) | 40 | 42 | 130 | 126 |
| Weighted average realized price(2) | $9,960 | $9,664 | $9,977 | $9,811 |
| Production volume (MT)(3) | 40 | 39 | 136 | 127 |
| Production capacity excluding St. Marys during idle period (MT)(4)(5) | 48 | 39 | 150 | 128 |
| Capacity utilization excluding St. Marys during idle period(4)(6) | 83% | 100% | 91% | 99% |
| Total production capacity (MT)(5)(7) | 55 | 46 | 171 | 149 |
| Total capacity utilization(6)(7) | 73% | 85% | 80% | 85% |
(1) Sales volume has been recast to reflect the total sales volume of GrafTech manufactured electrodes for which revenue has been recognized during the period. For additional information see "Key Operating Metrics" below.
(2) Weighted average realized price has been recast to reflect the total revenues from sales of GrafTech manufactured electrodes for the period divided by the GrafTech manufactured electrode volume for that period. For additional information see "Key Operating Metrics" below.
(3) Production volume reflects graphite electrodes we produced during the period.
(4) The St. Marys, Pennsylvania facility was temporarily idled effective the second quarter of 2016 except for the machining of semi‑finished products sourced from other plants. In the first quarter of 2018, our St. Marys facility began graphitizing a limited amount of electrodes sourced from our Monterrey, Mexico facility.
(5) Production capacity reflects expected maximum production volume during the period under normal operating conditions, standard product mix and expected maintenance outage. Actual production may vary.
(6) Capacity utilization reflects production volume as a percentage of production capacity.
(7) Includes graphite electrode facilities in Calais, France; Monterrey, Mexico; Pamplona, Spain and St. Marys, Pennsylvania.
Non‑GAAP financial measures
In addition to providing results that are determined in accordance with GAAP, we have provided certain financial measures that are not in accordance with GAAP. EBITDA from continuing operations and adjusted EBITDA from continuing operations are non‑GAAP financial measures. We define EBITDA from continuing operations, a non‑GAAP financial measure, as net income or loss plus interest expense, minus interest income, plus income taxes, discontinued operations and depreciation and amortization from continuing operations. We define adjusted EBITDA from continuing operations as EBITDA from continuing operations plus any pension and other post-employment benefit ("OPEB") plan expenses, initial and follow-on public offering expenses, non‑cash gains or losses from foreign currency remeasurement of non‑operating liabilities in our foreign subsidiaries where the functional currency is the U.S. dollar, related party Tax Receivable Agreement expense, stock-based compensation and non‑cash fixed asset write‑offs. Adjusted EBITDA from continuing operations is the primary metric used by our management and our board of directors to establish budgets and operational goals for managing our business and evaluating our performance.
We monitor adjusted EBITDA from continuing operations as a supplement to our GAAP measures, and believe it is useful to present to investors, because we believe that it facilitates evaluation of our period‑to‑period operating performance by eliminating items that are not operational in nature, allowing comparison of our recurring core business operating results over multiple periods unaffected by differences in capital structure, capital investment cycles and fixed asset base. In addition, we believe adjusted EBITDA from continuing operations and similar measures are widely used by investors, securities analysts, ratings agencies, and other parties in evaluating companies in our industry as a measure of financial performance and debt‑service capabilities.
Our use of adjusted EBITDA from continuing operations has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:
- adjusted EBITDA from continuing operations does not reflect changes in, or cash requirements for, our working capital needs;
- adjusted EBITDA from continuing operations does not reflect our cash expenditures for capital equipment or other contractual commitments, including any capital expenditure requirements to augment or replace our capital assets;
- adjusted EBITDA from continuing operations does not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our indebtedness;
- adjusted EBITDA from continuing operations does not reflect tax payments that may represent a reduction in cash available to us;
- adjusted EBITDA from continuing operations does not reflect expenses relating to our pension and OPEB plans;
- adjusted EBITDA from continuing operations does not reflect the non‑cash gains or losses from foreign currency remeasurement of non‑operating liabilities in our foreign subsidiaries where the functional currency is the U.S. dollar;
- adjusted EBITDA from continuing operations does not reflect initial and follow-on public offering expenses;
- adjusted EBITDA from continuing operations does not reflect related party Tax Receivable Agreement expense;
- adjusted EBITDA from continuing operations does not reflect stock-based compensation or the non‑cash write‑off of fixed assets; and
- other companies, including companies in our industry, may calculate EBITDA from continuing operations and adjusted EBITDA from continuing operations differently, which reduces its usefulness as a comparative measure.
In evaluating EBITDA from continuing operations and adjusted EBITDA from continuing operations, you should be aware that in the future, we will incur expenses similar to the adjustments in this presentation. Our presentations of EBITDA from continuing operations and adjusted EBITDA from continuing operations should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non‑recurring items. When evaluating our performance, you should consider EBITDA from continuing operations and adjusted EBITDA from continuing operations alongside other financial performance measures, including our net income (loss) and other GAAP measures.
The following table reconciles our non‑GAAP key financial measures to the most directly comparable GAAP measures:
(in thousands)
| For the Three Months Ended September 30, 2019 | 2018 | For the Nine Months Ended September 30, 2019 | 2018 | |
|---|---|---|---|---|
| Net income | 175,876 | 199,466 | 569,680 | 624,587 |
| Add: | ||||
| Discontinued operations | — | 726 | — | (585) |
| Depreciation and amortization | 15,357 | 16,050 | 46,387 | 47,746 |
| Interest expense | 31,803 | 33,855 | 98,472 | 100,387 |
| Interest income | (1,765) | (562) | (2,910) | (1,068) |
| Income taxes | 20,755 | 24,871 | 90,940 | 36,250 |
| EBITDA from continuing operations | 242,026 | 274,406 | 802,569 | 807,317 |
| Adjustments: | ||||
| Pension and OPEB plan expenses (1) | 800 | 483 | 2,397 | 1,478 |
| Initial and follow-on public offering expenses (2) | 160 | 43 | 1,409 | 5,164 |
| Non‑cash loss on foreign currency remeasurement (3) | (185) | 1,404 | 842 | 1,629 |
| Stock-based compensation (4) | 706 | 476 | 1,568 | 657 |
| Non‑cash fixed asset write-off (5) | 1,947 | — | 4,888 | 1,062 |
| Related party Tax Receivable Agreement expense (6) | — | — | — | 61,801 |
| Adjusted EBITDA from continuing operations | 245,454 | 276,812 | 813,673 | 879,108 |
(1) Service and interest cost of our OPEB plans. Also includes a mark‑to‑market loss (gain) for plan assets as of December of each year.
(2) Legal, accounting, printing and registration fees associated with the initial and follow-on public offerings.
(3) Non‑cash loss from foreign currency remeasurement of non‑operating liabilities of our non‑U.S. subsidiaries where the functional currency is the U.S. dollar.
(4) Non-cash expense for stock-based compensation grants.
(5) Non‑cash fixed asset write‑off recorded for obsolete assets.
(6) Non-cash expense for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized.
Key Operating Metrics
Key operating metrics consist of sales volume, weighted average realized price, production volume, production capacity and capacity utilization.
Sales volume reflects the total volume of GrafTech manufactured graphite electrodes sold for which revenue has been recognized during the period. Weighted average realized price reflects the total revenues from sales of GrafTech manufactured graphite electrodes for the period divided by the sales volume of the GrafTech manufactured electrodes for that period. Beginning in the first quarter of 2019, sales volume and weighted average realized price are presented excluding re-sales of low-grade graphite electrodes manufactured by third-party suppliers. Sales of these third-party manufactured electrodes are now included in the revenue category of “by-products and other,” which represents a minimal contribution to our profitability. This change aligns these metrics with management's assessment of our revenue performance and profit margin and will help investors understand the factors that drive our profitability. For comparability purposes, the prior period sales volume and weighted average realized price have been recast to conform to this presentation.
Production volume reflects graphite electrodes produced during the period. Production capacity reflects expected maximum production volume during the period under normal operating conditions, standard product mix and expected maintenance downtime. Capacity utilization reflects production volume as a percentage of production capacity. Production volume, production capacity and capacity utilization help us understand the efficiency of our production, evaluate cost of sales and consider how to approach our contract initiative.
Results of Operations
The Three Months Ended September 30, 2019 Compared to the Three Months Ended September 30, 2018
The tables presented in our period-over-period comparisons summarize our Condensed Consolidated Statements of Operations and illustrate key financial indicators used to assess the consolidated financial results. Throughout our Management's Discussion and Analysis ("MD&A"), insignificant changes may be deemed not meaningful and are generally excluded from the discussion.
(Dollars in thousands)
| For the Three Months Ended September 30, 2019 | 2018 | Increase/ Decrease | % Change | |
|---|---|---|---|---|
| Net sales | $420,797 | $454,890 | $(34,093) | (7)% |
| Cost of sales | 178,497 | 180,280 | (1,783) | (1)% |
| Gross profit | 242,300 | 274,610 | (32,310) | (12)% |
| Research and development | 611 | 518 | 93 | 18% |
| Selling and administrative expenses | 15,708 | 14,234 | 1,474 | 10% |
| Operating income | 225,981 | 259,858 | (33,877) | (13)% |
| Other (income) expense, net | (688) | 1,502 | (2,190) | (146)% |
| Interest expense | 31,803 | 33,855 | (2,052) | (6)% |
| Interest income | (1,765) | (562) | (1,203) | 214% |
| Income from continuing operations before provision for income taxes | 196,631 | 225,063 | (28,432) | (13)% |
| Provision for income taxes | 20,755 | 24,871 | (4,116) | (17)% |
| Net income from continuing operations | 175,876 | 200,192 | (24,316) | (12)% |
| Loss from discontinued operations, net of tax | — | (726) | 726 | (100)% |
| Net income | $175,876 | $199,466 | $(23,590) | (12)% |
Net sales. Net sales decreased from $454.9 million in the three months ended September 30, 2018 to $420.8 million in the three months ended September 30, 2019. The decrease was primarily driven by a 5% decrease in sales volume of graphite electrodes. Partially offsetting this decrease in volumes was an increase in the weighted average realized price to $9,960 per MT in the three months ended September 30, 2019 from $9,664 per MT in the same period of the prior year. These increases were partially offset by decreased sales of by-products and other.
Cost of sales. We experienced a decrease in cost of sales from $180.3 million in the three months ended September 30, 2018 to $178.5 million in the three months ended September 30, 2019 as a result of lower sales volume. This decrease was partially offset by sales of inventory that was manufactured using higher priced third-party needle coke.
Selling and administrative expenses. Selling and administrative expenses increased by $1.5 million, or 10%, from $14.2 million in the three months ended September 30, 2018 to $15.7 million in the three months ended September 30, 2019. This change was primarily due to the write-off of receivables related to a customer that entered into bankruptcy proceedings.
Other expense (income). Other expense (income) decreased from $1.5 million of expense in the three months ended September 30, 2018 to $0.7 million of income in the three months ended September 30, 2019, primarily due to $1.6 million of advantageous non‑cash foreign currency impacts on non‑operating assets and liabilities.
Interest Expense. Interest expense decreased from $33.9 million in the three months ended September 30, 2018, to $31.8 million in the three months ended September 30, 2019, primarily due to reduced borrowings resulting from our $125.0 million payment on our term loans in February 2019.
Provision for income taxes. The following table summarizes the expense for income taxes:
(Dollars in thousands)
| For the Three Months Ended September 30, 2019 | 2018 | |
|---|---|---|
| Tax expense | $20,755 | $24,871 |
| Pretax income | 196,631 | 225,063 |
| Effective tax rates | 10.6% | 11.1% |
The effective tax rate for the three months ended September 30, 2019 was 10.6%. This rate differs from the U.S. statutory rate of 21% primarily due to worldwide earnings from various countries taxed at different rates and further improved by the provision to return adjustment recorded in the third quarter as a result of filing income tax returns in foreign jurisdictions
The effective tax rate for the three months ended September 30, 2018 was 11.1%. This rate differs from the U.S. statutory rate of 21% primarily due to the partial release of a valuation allowance recorded against the deferred tax asset related to U.S. tax attributes and the tax impact of worldwide earnings from various countries taxed at different rates.
Tax expense decreased from $24.9 million for the three months ended September 30, 2018 to $20.8 million for the three months ended September 30, 2019. This change is primarily related the reduction in profits and further reduced by the provision to return adjustment recorded in the third quarter as a result of filing income tax returns in foreign jurisdictions.
The Nine Months Ended September 30, 2019 Compared to the Nine Months Ended September 30, 2018
The tables presented in our period-over-period comparisons summarize our Condensed Consolidated Statements of Operations and illustrate key financial indicators used to assess the consolidated financial results. Throughout our MD&A, insignificant changes may be deemed not meaningful and are generally excluded from the discussion.
(Dollars in thousands)
| For the Nine Months Ended September 30, 2019 | 2018 | Increase/ Decrease | % Change | |
|---|---|---|---|---|
| Net sales | $1,376,181 | $1,363,121 | $13,060 | 1% |
| Cost of sales | 571,068 | 491,339 | 79,729 | 16% |
| Gross profit | 805,113 | 871,782 | (66,669) | (8)% |
| Research and development | 1,961 | 1,528 | 433 | 28% |
| Selling and administrative expenses | 46,328 | 46,349 | (21) | —% |
| Operating income | 756,824 | 823,905 | (67,081) | (8)% |
| Other expense | 642 | 2,533 | (1,891) | (75)% |
| Related party Tax Receivable Agreement expense | — | 61,801 | (61,801) | N/A |
| Interest expense | 98,472 | 100,387 | (1,915) | (2)% |
| Interest income | (2,910) | (1,068) | (1,842) | 172% |
| Income from continuing operations before provision for income taxes | 660,620 | 660,252 | 368 | —% |
| Provision for income taxes | 90,940 | 36,250 | 54,690 | 151% |
| Net income from continuing operations | 569,680 | 624,002 | (54,322) | (9)% |
| Income from discontinued operations, net of tax | — | 585 | (585) | (100)% |
| Net income | $569,680 | $624,587 | $(54,907) | (9)% |
Net sales. Net sales increased by $13.1 million, or 1%, from $1,363.1 million in the nine months ended September 30, 2018 to $1,376.2 million in the nine months ended September 30, 2019. This increase was driven by a 3% increase in sales volume in the nine months ended September 30, 2019 compared to the same period in 2018, primarily due to the completion of our debottlenecking initiative. The weighted average realized price of GrafTech manufactured graphite electrodes was $9,977 per MT in the nine months ended September 30, 2019, which was slightly higher than the $9,811 per MT we realized in the nine months ended September 30, 2018. These increases were partially offset by decreased sales of by-products and other.
Cost of sales. Cost of sales increased by $79.7 million, or 16%, from $491.3 million in the nine months ended September 30, 2018 to $571.1 million in the nine months ended September 30, 2019. This increase was primarily the result of higher input costs for needle coke and higher volumes, increasing as a result of our debottlenecking projects coming online.
Selling and administrative expenses. Selling and administrative expenses were flat for the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018 as decreased costs related to our public offerings of $3.8 million were offset by an increase to the allowance for doubtful accounts related to a customer that entered into bankruptcy proceedings and the ongoing costs of being a public company.
Other expense (income). Other expense decreased by $1.9 million, or 75%, from $2.5 million in the nine months ended September 30, 2018 to $0.6 million in the nine months ended September 30, 2019. This decrease was primarily due to advantageous non‑cash foreign currency impacts on non‑operating assets and liabilities.
Related party Tax Receivable Agreement expense. During the second quarter of 2018, the Company recorded $61.8 million of expense as a result of our tax receivable agreement liability, after it was estimated that we would realize certain deferred tax assets.
Interest expense. Interest expense was largely consistent in the nine months ended September 30, 2019 compared to the same period of 2018. In the first quarter of 2018, we redeemed our Senior Notes resulting in accelerated accretion of the fair value adjustment on the Senior Notes of $18.7 million and a premium redemption of $4.8 million. This decrease was offset by increased borrowing costs due to higher levels of debt in the nine months ended September 30, 2019.
Provision for income taxes. The following table summarizes the expense for income taxes:
(Dollars in thousands)
| For the Nine Months Ended September 30, 2019 | 2018 | |
|---|---|---|
| Tax expense | $90,940 | $36,250 |
| Pretax income | 660,620 | 660,252 |
| Effective tax rates | 13.8% | 5.5% |
The effective tax rate for the nine months ended September 30, 2019 was 13.8%. This rate differs from the U.S. statutory rate of 21% primarily due to worldwide earnings from various countries taxed at different rates.
The effective tax rate for the nine months ended September 30, 2018 was 5.5%. This rate differed from the U.S. statutory rate of 21% primarily due to the partial release of a valuation allowance recorded against the deferred tax asset related to U.S. tax attributes worldwide earnings from various countries taxed at different rates.
Tax expense increased from $36.3 million for the nine months ended September 30, 2018, to $90.9 million for the nine months ended September 30, 2019. This change is primarily due to a partial release in the first nine months of 2018 of a valuation allowance recorded against the deferred tax asset related to US tax attributes.
Effects of Changes in Currency Exchange Rates
When the currencies of non-U.S. countries in which we have a manufacturing facility decline (or increase) in value relative to the U.S. dollar, this has the effect of reducing (or increasing) the U.S. dollar equivalent cost of sales and other expenses with respect to those facilities. In certain countries in which we have manufacturing facilities, and in certain export markets, we sell in currencies other than the U.S. dollar. Accordingly, when these currencies increase (or decline) in value relative to the U.S. dollar, this has the effect of increasing (or reducing) net sales. The result of these effects is to increase (or decrease) operating profit and net income.
Many of the non-U.S. countries in which we have a manufacturing facility have been subject to significant economic and political changes, which have significantly impacted currency exchange rates. We cannot predict changes in currency exchange rates in the future or whether those changes will have net positive or negative impacts on our net sales, cost of sales or net income.
The impact of these changes in the average exchange rates of other currencies against the U.S. dollar on our net sales was an increase of $0.2 million and a decrease of $4.0 million for the three and nine months ended September 30, 2019, respectively, compared to the same period of 2018. The impact of these changes on our cost of sales was decreases of $2.1 million and $10.6 million for the three and nine months ended September 30, 2019, respectively, compared to the same period of 2018.
We have in the past and may in the future use various financial instruments to manage certain exposures to risks caused by currency exchange rate changes, as described under “Part I, Item 3–Quantitative and Qualitative Disclosures about Market Risk”.
Liquidity and Capital Resources
Our sources of funds have consisted principally of cash flow from operations and debt, including our credit facilities (subject to continued compliance with the financial covenants and representations). Our uses of those funds (other than for operations) have consisted principally of dividends, capital expenditures, scheduled debt repayments, optional debt prepayments, share repurchases and other obligations. Disruptions in the U.S. and international financial markets could adversely affect our liquidity and the cost and availability of financing to us in the future.
We believe that we have adequate liquidity to meet our needs. As of September 30, 2019, we had liquidity of $628.1 million consisting of $246.9 million of availability on our 2018 Revolving Facility (subject to continued compliance with the financial covenants and representations) and cash and cash equivalents of $381.2 million. We had long‑term debt of $1,965.5 million and short‑term debt of $70.9 million as of September 30, 2019. As of December 31, 2018, we had liquidity of $295.4 million consisting of $245.5 million available on our 2018 Revolving Facility (subject to continued compliance with the financial covenants and representations) and cash and cash equivalents of $49.9 million. We had long‑term debt of $2,050.3 million and short‑term debt of $106.3 million as of December 31, 2018.
As of September 30, 2019 and December 31, 2018, $176.6 million and $38.4 million, respectively, of our cash and cash equivalents were located outside of the United States. We repatriate funds from our foreign subsidiaries through dividends. All of our subsidiaries face the customary statutory limitation that distributed dividends do not exceed the amount of retained and current earnings. In addition, for our subsidiary in South Africa, the South Africa Central Bank requires that certain solvency and liquidity ratios remain above defined levels after the dividend distribution, which historically has not materially affected our ability to repatriate cash from this jurisdiction. The cash and cash equivalents balances in South Africa were $1.6 million and $0.2 million as of September 30, 2019 and December 31, 2018, respectively. Upon repatriation to the United States, the foreign source portion of dividends we receive from our foreign subsidiaries is no longer subject to U.S. federal income tax as a result of the Tax Act.
Cash flow and plans to manage liquidity. Our cash flow typically fluctuates significantly between quarters due to various factors. These factors include customer order patterns, fluctuations in working capital requirements, timing of tax payments, timing of capital expenditures, acquisitions, divestitures and other factors. Cash flow from operations is expected to remain at positive sustained levels due to the predictable earnings generated by our three-to-five-year sales contracts with our customers.
As of September 30, 2019, we had access to the $250 million 2018 Revolving Facility. We had $3.1 million of letters of credit, for a total availability on the 2018 Revolving Facility of $246.9 million. We also had $2.5 million of surety bonds outstanding as of September 30, 2019. As of December 31, 2018, we had availability on the 2018 Revolving Faciltity of $245.5 million resulting from $4.5 million of letters of credit. We also had $0.5 million of surety bonds outstanding as of December 31, 2018.
On February 12, 2018, we entered into the 2018 Credit Agreement, which provides for the 2018 Revolving Facility and the 2018 Term Loan Facility. On February 12, 2018, our wholly owned subsidiary, GrafTech Finance, borrowed $1,500 million under the 2018 Term Loan Facility. The funds received were used to pay off our outstanding debt, including borrowings under our Old Credit Agreement and the Senior Notes and accrued interest relating to those borrowings and the Senior Notes, declare and pay a dividend of $1,112.0 million to our sole pre-IPO stockholder, pay fees and expenses incurred in connection therewith and for other general corporate purposes.
On April 19, 2018, we declared a dividend in the form of the Brookfield Promissory Note to the sole pre-IPO stockholder. The $750 million Brookfield Promissory Note was conditioned upon (i) the Senior Secured First Lien Net Leverage Ratio (as defined in the 2018 Credit Agreement), as calculated based on our final financial results for the first quarter of 2018, being equal to or less than 1.75 to 1.00, (ii) no Default or Event of Default (each as defined in the 2018 Credit Agreement) having occurred and continuing or that would result from the $750 million Brookfield Promissory Note and (iii) the satisfaction of the conditions described in (i) and (ii) above occurring within 60 days from the dividend record date. Upon publication of our 2018 first quarter report on Form 10-Q, these conditions were met and, as a result, the Brookfield Promissory Note became payable.
The Brookfield Promissory Note had a maturity of eight years from the date of issuance and bore interest at a rate equal to the Adjusted LIBO Rate (as defined in the Brookfield Promissory Note) plus an applicable margin equal to 4.50% per annum, with an additional 2.00% per annum starting from the third anniversary from the date of issuance. We were permitted to make voluntary prepayments at any time without premium or penalty. All obligations under the Brookfield Promissory Note were unsecured and guaranteed by all of our existing and future domestic wholly owned subsidiaries that guarantee, or are borrowers under, the Senior Secured Credit Facilities. No funds were lent or otherwise contributed to us by Brookfield in connection with the Brookfield Promissory Note. As a result, we received no consideration in connection with its issuance. As described below, the Brookfield Promissory Note was repaid, in full, on June 15, 2018.
On April 19, 2018, we declared a $160 million cash dividend payable to Brookfield, the sole pre-IPO stockholder. Payment of this dividend was conditional upon (i) the Senior Secured First Lien Net Leverage Ratio (as defined in the 2018 Credit Agreement), as calculated based on our final financial results for the first quarter of 2018, being equal to or less than 1.75 to 1.00, (ii) no Default or Event of Default (as defined in the 2018 Credit Agreement) having occurred and continuing or that would result from the payment of the dividend and (iii) the payment occurring within 60 days from the dividend record date. The conditions of this dividend were met upon filing of our first quarter 2018 report on Form 10-Q and the dividend was paid on May 8, 2018.
On June 15, 2018, GrafTech entered into the First Amendment to its 2018 Credit Agreement. The First Amendment amends the 2018 Credit Agreement to provide for the additional $750 million in aggregate principal amount of the Incremental Term Loans to GrafTech Finance. The Incremental Term Loans increase the aggregate principal amount of term loans incurred by GrafTech Finance under the 2018 Credit Agreement from $1,500 million to $2,250 million. The Incremental Term Loans have the same terms as those applicable to the existing term loans under the 2018 Credit Agreement, including interest rate, payment and prepayment terms, representations and warranties and covenants. The Incremental Term Loans mature on February 12, 2025, the same date as the existing term loans. GrafTech paid an upfront fee of 1.00% of the aggregate principal amount of the Incremental Term Loans on the effective date of the First Amendment. The proceeds of the Incremental Term Loans were used to repay, in full, the $750 million in principal outstanding on the Brookfield Promissory Note.
On August 13, 2018, the Company repurchased 11,688,311 shares directly from Brookfield. These shares were retired upon repurchase. The price per share paid by the Company was equal to the price at which the underwriters purchased the shares from Brookfield in Brookfield’s August 2018 public secondary offering of 23,000,000 shares of our common stock, net of underwriting commissions and discounts. GrafTech funded the share repurchase from cash on hand.
On July 30, 2019, our Board of Directors authorized a program to repurchase up to $100 million of our outstanding common stock. We may purchase shares from time to time on the open market, including under Rule 10b5-1 and/or Rule 10b-18 plans. The amount and timing of repurchases are subject to a variety of factors including liquidity, stock price, applicable legal requirements, other business objectives and market conditions. As of September 30, 2019 we had repurchased 879,134 shares of common stock totaling $9.5 million under this program.
We currently pay a quarterly cash dividend of $0.085 per share, or an aggregate of $0.34 per share on an annualized basis. Additionally, on December 31, 2018, we paid a special dividend of $0.70 per share totaling $203.4 million. There can be no assurance that we will pay dividends in the future in these amounts or at all. Our Board of Directors may change the timing and amount of any future dividend payments or eliminate the payment of future dividends in its sole discretion, without any prior notice to our stockholders. Our ability to pay dividends will depend upon many factors, including our financial position and liquidity, results of operations, legal requirements, restrictions that may be imposed by the terms of our current and future credit facilities and other debt obligations and other factors deemed relevant by our Board of Directors.
On February 13, 2019, we repaid $125 million on our 2018 Term Loan Facility. We are targeting to return approximately 50-60% of our cash flow after capital expenditures to stockholders in 2019 with the remainder to be used for debt repayment. During the nine months ended September 30, 2019, we paid $87.0 million to various tax collecting agencies worldwide.
Potential uses of our liquidity include dividends, share repurchases, capital expenditures, acquisitions, scheduled debt repayments, optional debt prepayments and other general purposes. An improving economy, while resulting in improved results of operations, could increase our cash requirements to purchase inventories, make capital expenditures and fund payables and other obligations until increased accounts receivable are converted into cash. A downturn could significantly and negatively impact our results of operations and cash flows, which, coupled with increased borrowings, could negatively impact our credit ratings, our ability to comply with debt covenants, our ability to secure additional financing and the cost of such financing, if available.
In order to seek to minimize our credit risks, we may reduce our sales of, or refuse to sell (except for prepayment, cash on delivery or under letters of credit or parent guarantees), our products to some customers and potential customers. Our unrecovered trade receivables worldwide have not been material during the last two years individually or in the aggregate.
We manage our capital expenditures by taking into account quality, plant reliability, safety, environmental and regulatory requirements, prudent or essential maintenance requirements, global economic conditions, available capital resources, liquidity, long‑term business strategy and return on invested capital for the relevant expenditures, cost of capital and return on invested capital of the Company as a whole and other factors.
We have announced a series of operational improvement projects at our Monterrey and St. Marys facilities. These projects are intended to help optimize our manufacturing footprint while improving environmental performance and increasing production flexibility. We expect these projects to be completed in the first half of 2021, at which time we will be able to shift additional graphitization and machining from Monterrey to St. Marys. We estimate that capital spending would be near current levels which includes these projects as well as maintenance and capital projects, subject to the approval by our Board.
In the event that operating cash flows fail to provide sufficient liquidity to meet our business needs, including capital expenditures, any such shortfall would need to be made up by increased borrowings under our 2018 Revolving Facility, to the extent available.
Cash Flows
The following table summarizes our cash flow activities:
in millions
| Cash flow provided by (used in): | For the Nine Months Ended September 30, 2019 | 2018 |
|---|---|---|
| Operating activities | $584.8 | $612.2 |
| Investing activities | $(44.0) | $(46.8) |
| Financing activities | $(208.5) | $(474.7) |
Operating Activities
Cash flow from operating activities represents cash receipts and cash disbursements related to all of our activities other than investing and financing activities. Operating cash flow is derived by adjusting net income (loss) for:
- Non-cash items such as depreciation and amortization, impairment, post retirement obligations, and severance and pension plan changes;
- Gains and losses attributed to investing and financing activities such as gains and losses on the sale of assets and unrealized currency transaction gains and losses; and
- Changes in operating assets and liabilities which reflect timing differences between the receipt and payment of cash associated with transactions and when they are recognized in results of operations.
The net impact of the changes in working capital (operating assets and liabilities), which are discussed in more detail below, include the impact of changes in: receivables, inventories, prepaid expenses, accounts payable, accrued liabilities, accrued taxes, interest payable, and payments of other current liabilities.
During the nine months ended September 30, 2019, changes in working capital resulted in a net use of funds of $80.3 million which was impacted by:
- net cash outflows in accounts receivable of $20.7 million from the increase in accounts receivable due to the timing of sales and collections;
- net cash outflows from increases in inventory of $19.9 million, due primarily to higher priced raw materials;
- net cash inflows from the utilization of prepaid assets of $5.7 million;
- net cash outflows from decreased income taxes payable of $28.2 million resulting from required tax payments as our profitability has increased; and
- net cash outflows from decreases in accounts payable and accruals of $17.3 million, due to the timing of payments.
Uses of cash in the nine months ended September 30, 2019 included contributions to pension and other benefit plans of $2.3 million, cash paid for interest of $93.6 million and taxes paid of $87.0 million.
During the nine months ended September 30, 2018, changes in working capital resulted in a net use of funds of $143.7 million which was impacted by:
- net cash outflows in accounts receivable of $96.0 million from the increase in accounts receivable due to increased sales driven by higher weighted average realized prices, partially offset by improved collections;
- net cash outflows from increases in inventory of $93.8 million, due primarily to higher priced raw materials;
- net cash inflows from increases in accounts payable of $4.3 million, due primarily to higher priced raw materials;
- net cash inflows from decreased prepaid expense of $7.8 million due to the reduction of advanced payments; and
- net cash inflows from increased income taxes payable of $35.4 million resulting from increased profitability.
Other uses of cash in the nine months ended September 30, 2018 included contributions to pension and other benefit plans of $6.6 million, cash paid for interest of $74.5 million and taxes paid of $19.4 million.
Investing Activities
Net cash used in investing activities was $44.0 million during the nine months ended September 30, 2019, resulting from capital expenditures.
Net cash used in investing activities was $46.8 million during the nine months ended September 30, 2018, resulting from capital expenditures of $47.6 million partially offset by proceeds from the sale of fixed assets of $0.9 million.
Financing Activities
Net cash outflow from financing activities was $208.5 million during the nine months ended September 30, 2019, which was the result of our $125.0 million payment on our long-term debt, $74.0 million of total dividends to stockholders and $9.5 million of stock repurchases.
Net cash outflow from financing activities was $474.7 million during the nine months ended September 30, 2018, which was the net impact of our February 12, 2018 refinancing and subsequent amendment, proceeds of which were used to repay outstanding debt, pay dividends of $1,316.2 million, and repay the $750 million Brookfield Promissory Note to Brookfield. We also repurchased $225 million of our common stock from Brookfield on August 13, 2018.
Related Party Transactions
We have engaged, from time to time, in transactions with affiliates or related parties and we expect to continue to do so in the future. These transactions include, among others, entry into agreements with Brookfield such as the Stockholder Rights Agreement, the Registration Rights Agreement, the Tax Receivable Agreement and the Share Repurchase Agreement.
We have also reimbursed certain costs incurred by Brookfield as required under the Investment Agreement dated May 4, 2015 between Brookfield and GrafTech, including in connection with, transactions with our current or former subsidiaries, compensatory transactions with directors and officers including employee benefits (including reimbursement to Brookfield for compensation costs incurred by it for certain personnel who devote substantially all of their working time to us), stock option and restricted stock grants, compensation deferral, stock purchases, and customary indemnification and expense advancement arrangements.
Recent Accounting Pronouncements
We discuss recently adopted accounting standards in Note 1, “Organization and Summary of Significant Accounting Policies” of the Notes to Condensed Consolidated Financial Statements.
Description of Our Financing Structure
We discuss our financing structure in more detail in Note 6, “Debt and Liquidity” of the Notes to Condensed Consolidated Financial Statements.
Market risk
As filed, 4,813 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are exposed to market risks, primarily from changes in interest rates, currency exchange rates, energy commodity prices and commercial energy rates. From time to time, we enter into transactions that have been authorized according to documented policies and procedures in order to manage these risks. These transactions relate primarily to financial instruments described below. Since the counterparties to these financial instruments are large commercial banks and similar financial institutions, we do not believe that we are exposed to material counterparty credit risk. We do not use financial instruments for trading purposes.
Our exposure to changes in interest rates results primarily from floating rate long‑term debt tied to LIBO Rate or Euro LIBO Rate.
Our exposure to changes in currency exchange rates results primarily from:
- sales made by our subsidiaries in currencies other than local currencies;
- raw material purchases made by our foreign subsidiaries in currencies other than local currencies; and
- investments in and intercompany loans to our foreign subsidiaries and our share of the earnings of those subsidiaries, to the extent denominated in currencies other than the U.S. dollar.
Our exposure to changes in energy commodity prices and commercial energy rates results primarily from the purchase or sale of refined oil products and the purchase of natural gas and electricity for use in our manufacturing operations.
Interest rate risk management. We periodically enter into agreements with financial institutions that are intended to limit our exposure to additional interest expense due to increases in variable interest rates. These instruments effectively cap our interest rate exposure. During the third quarter of 2019, we entered into interest rate swaps resulting in a net unrealized pre-tax gain of $0.7 million as of September 30, 2019.
Currency rate management. We enter into foreign currency derivatives from time to time to attempt to manage exposure to changes in currency exchange rates. These foreign currency derivatives, which include, but are not limited to, forward exchange contracts and purchased currency options, attempt to hedge global currency exposures. Forward exchange contracts are agreements to exchange different currencies at a specified future date and at a specified rate. Purchased currency options are instruments which give the holder the right, but not the obligation, to exchange different currencies at a specified rate at a specified date or over a range of specified dates. Forward exchange contracts and purchased currency options are carried at market value.
The outstanding foreign currency derivatives represented a net loss of $0.8 million as of September 30, 2019 and no net gain or loss as of December 31, 2018.
Energy commodity management. We have entered into commodity derivative contracts to effectively fix some or all of our exposure to refined oil products. The outstanding commodity derivative contracts represented a net unrealized pre-tax loss of $17.2 million and $10.7 million as of September 30, 2019 and December 31, 2018, respectively.
Sensitivity analysis. We use sensitivity analysis to quantify potential impacts that market rate changes may have on the underlying exposures as well as on the fair values of our derivatives. The sensitivity analysis for the derivatives represents the hypothetical changes in value of the hedge position and does not reflect the related gain or loss on the forecasted underlying transaction.
A hypothetical increase in interest rates of 100 basis points (1%) would have increased our interest expense by $15.0 million for the nine months ended September 30, 2019. The same 100 basis points increase would have resulted in an increase of $28.9 million in the fair value of our interest rate swap portfolio.
As of September 30, 2019, a 10% appreciation or depreciation in the value of the U.S. dollar against foreign currencies from the prevailing market rates would have resulted in a corresponding decrease of $4.8 million or a corresponding increase of $4.8 million, respectively, in the fair value of the foreign currency hedge portfolio.
A 10% increase or decrease in the value of the underlying commodity prices that we hedge would have resulted in a corresponding increase or decrease of $11.1 million in the fair value of the commodity hedge portfolio as of September 30, 2019. Because of the high correlation between the hedging instrument and the underlying exposure, fluctuations in the value of the instruments are generally offset by reciprocal changes in the value of the underlying exposure.
For further information related to the financial instruments described above, see Note 11 "Derivative Instruments" to the Consolidated Financial Statements.
Controls and procedures
As filed, 1,713 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures. Management is responsible for establishing and maintaining adequate disclosure controls and procedures at the reasonable assurance level. Disclosure controls and procedures are designed to ensure that information required to be disclosed by a reporting company in the reports that it files or submits under the Section 13 or 15(d) of the Securities and Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by it in the reports that it files under the Exchange Act is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2019. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that these controls and procedures are effective at the reasonable assurance level as of September 30, 2019.
Changes in Internal Control over Financial Reporting. There have been no changes in our internal control over financial reporting that occurred during the three months ended September 30, 2019 that materially affected or are reasonably likely to materially affect our internal control over financial reporting.
Risk factors
As filed, 147 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to the Risk Factors disclosed in Part I - Item 1A of our Annual Report on Form 10-K filed on February 22, 2019.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-07-01 to 2019-09-30 | $420.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2019-01-01 to 2019-09-30 | $1.38bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2019-07-01 to 2019-09-30 | $178.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2019-01-01 to 2019-09-30 | $571.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-07-01 to 2019-09-30 | $242.3m | us-gaap:GrossProfit |
| Gross profit | 9 months2019-01-01 to 2019-09-30 | $805.1m | us-gaap:GrossProfit |
| Research and development | 3 months2019-07-01 to 2019-09-30 | $611.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2019-01-01 to 2019-09-30 | $2.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2019-07-01 to 2019-09-30 | $15.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2019-01-01 to 2019-09-30 | $46.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-07-01 to 2019-09-30 | $226.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-01-01 to 2019-09-30 | $756.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-07-01 to 2019-09-30 | $31.8m | us-gaap:InterestExpense |
| Interest expense | 9 months2019-01-01 to 2019-09-30 | $98.5m | us-gaap:InterestExpense |
| Income tax | 3 months2019-07-01 to 2019-09-30 | $20.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2019-01-01 to 2019-09-30 | $90.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-07-01 to 2019-09-30 | $175.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-01-01 to 2019-09-30 | $569.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-07-01 to 2019-09-30 | $0.61 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2019-01-01 to 2019-09-30 | $1.96 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-07-01 to 2019-09-30 | $0.61 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2019-01-01 to 2019-09-30 | $1.96 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-07-01 to 2019-09-30 | 290,127,296 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2019-01-01 to 2019-09-30 | 290,422,351 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2019-01-01 to 2019-09-30 | $584.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2019-01-01 to 2019-09-30 | $44.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2019-01-01 to 2019-09-30 | $15.5m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2019-01-01 to 2019-09-30 | $9.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-09-30 | $381.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-09-30 | $1.00bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-09-30 | $1.83bn | us-gaap:Assets |
| Current liabilities | At period end2019-09-30 | $276.2m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2019-09-30 | $1.97bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-09-30 | $70.9m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2019-09-30 | $70.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2019-09-30 | −$606.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000931148-19-000050. Last ingested by Listed: Nov 10, 2026, 00:15 ET. Listed shows no prices and gives no investment advice.